The Glycosyltransferase ST6Gal-I Protects Tumor Cells against Serum Growth Factor Withdrawal by Enhancing Survival Signaling and Proliferative Potential
Authors:
Open Access
- 1 March 2017
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 292 (11) , 4663-4673
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 GM111093, R21 CA192629)
This publication has 50 references indexed in Scilit:
- ST6Gal-I Regulates Macrophage Apoptosis via α2-6 Sialylation of the TNFR1 Death ReceptorJournal of Biological Chemistry, 2011
- Sialylation of the Fas Death Receptor by ST6Gal-I Provides Protection against Fas-mediated Apoptosis in Colon Carcinoma CellsJournal of Biological Chemistry, 2011
- Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cellsProceedings of the National Academy of Sciences, 2011
- Glycome Diagnosis of Human Induced Pluripotent Stem Cells Using Lectin MicroarrayJournal of Biological Chemistry, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- α2,6-Sialic Acid on Platelet Endothelial Cell Adhesion Molecule (PECAM) Regulates Its Homophilic Interactions and Downstream Antiapoptotic SignalingJournal of Biological Chemistry, 2010
- Is NF-κB a good target for cancer therapy? Hopes and pitfallsNature Reviews Drug Discovery, 2009
- Sialylation of 1 Integrins Blocks Cell Adhesion to Galectin-3 and Protects Cells against Galectin-3-induced ApoptosisJournal of Biological Chemistry, 2008
- Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKKGenes & Development, 2008
- NF-κB at the crossroads of life and deathNature Immunology, 2002